Alignment of European Regulatory and Health Technology Assessments: A Review of Licensed Products for Alzheimer's Disease

Aims: To facilitate regulatory learning, we evaluated similarities and differences in evidence requirements between regulatory and health technology assessment (HTA) bodies of Alzheimer's disease (AD) approved products. Methods: The European marketing authorisation application dossiers and Euro...

Descripción completa

Detalles Bibliográficos
Autores principales: Dekker, Marieke J. H. J., Bouvy, Jacoline C., O'Rourke, Diana, Thompson, Robin, Makady, Amr, Jonsson, Pall, Gispen-de Wied, Christine C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515927/
https://www.ncbi.nlm.nih.gov/pubmed/31134200
http://dx.doi.org/10.3389/fmed.2019.00073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515927/
https://www.ncbi.nlm.nih.gov/pubmed/31134200
http://dx.doi.org/10.3389/fmed.2019.00073

Ejemplares similares